Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome

Bone Marrow Transplant. 2024 Sep;59(9):1332-1334. doi: 10.1038/s41409-024-02365-5. Epub 2024 Jul 9.

Affiliations

¹ Department for Internal Medicine 2, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany. [email protected].
² Department for Internal Medicine 2, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany.

^# Contributed equally.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Allografts
Female
Hematopoietic Stem Cell Transplantation* / methods
Humans
Male
Middle Aged
Myelodysplastic Syndromes* / therapy
Transplantation, Homologous / methods
Treatment Outcome